SIBNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

SI-BONE, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026

$19.66−0.02 (-0.10%)

Close on Oct 19, 2026

Market cap: $874.42M
P/E (TTM): –
Dividend yield: 0.00%

SI-BONE, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31
Revenue	201	167	139	106	90	73	67	55	48
Cost of Revenue	41	35	29	16	10	8.90	6.79	4.83	5.11
Gross Profit	160	132	109	91	80	64	61	51	43
Research & Development	17	17	15	14	12	9.46	7.28	5.38	5.51
Selling, General & Admin	165	151	141	137	119	94	89	57	55
Selling & Marketing	124	117	110	108	94	74	68	44	42
General & Administrative	41	34	31	29	25	20	21	13	13
Advertising Expenses	0.50	0.50	1.10	1.60	1.20	0.30	0.40	0.70	0.80
Operating Expenses	182	167	156	150	131	103	97	63	60
Operating Income	-22	-35	-47	-60	-52	-39	-36	-12	-17
Interest Expense	2.63	3.44	3.46	2.82	5.37	6.10	4.95	5.11	6.20
Interest & Investment Income	6.07	7.85	6.92	1.30	0.19	1.10	2.55	0.77	0.18
Other Non-Operating Income	-0.02	-0.07	0.14	-0.13	0.28	-0.13	0.00	-1.15	0.34
Asset Impairment Charges	0	0	0	0	0	0	0	0	0
Gain (Loss) on Investments	–	–	–	–	0	0.05	0	–	–
Gain (Loss) on Sale of Assets	-1.63	-1.88	-1.30	-0.15	-0.40	-0.38	-0.17	-0.05	-0.21
Pretax Income	–	–	–	–	–	-44	-38	-17	-23
Income Tax Expense	0	0	0	0	0	–	–	0	0
Net Income	-19	-31	-43	-61	-57	-44	-38	-17	-23
EPS (Basic)(per share)	-0.44	-0.75	-1.13	-1.79	-1.71	-1.50	-1.55	-2.20	-6.65
EPS (Diluted)(per share)	-0.44	-0.75	-1.13	-1.79	-1.71	-1.50	-1.55	-2.20	-6.65
Shares Outstanding (Basic, Weighted)(shares)	43	41	38	34	33	29	25	7.95	3.47
Shares Outstanding (Diluted, Weighted)(shares)	43	41	38	34	33	29	25	7.95	3.47
Dividend per Share(per share)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	-17	-31	-42	-56	-50	-37	-35	-11	-16

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 79.5%
Operating margin: -8.3%
Net margin: -6.9%
Return on equity, FY2025: -11.0%

Financial strength

Current ratio: 9.15
Debt to equity: 0.20
Debt to assets: 14.3%
Cash to current liabilities: 137.8%

Valuation

P/E ratio: –
Price to sales: 4.09
Price to book: 4.80
Dividend yield: 0.00%